See All Slides - tctmd.com

Slides

Presentation TCT 2014

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Presenter: Bernard De Bruyne

September 16, 2014

Presentation TCT 2014

Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

Presenter: Ming Kai Lam

September 16, 2014

Presentation TCT 2014

Tissue Removal Assessment with Ultrasound of the SFA and Popliteal Study (TRUTH): Orbital Atherectomy Acute Data and Intravascular Ultrasound Analysis

Presenter: Anvar Babaev

September 16, 2014

Presentation TCT 2014

Utility of Fractional Flow Reserve Assessment in Aortic Stenosis

Presenter: Edward Coverstone

September 16, 2014

Presentation TCT 2014

Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE

Presenter: Fausto Feres

September 16, 2014

Presentation TCT 2014

Predictors For Tissue Embolization During Transcatheter Aortic Valve Implantation

Presenter: Ramon Rodriguez-Olivares

September 16, 2014

Presentation TCT 2014

Short-Duration Versus Guideline-Recommended 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation

Presenter: Giulio Stefanini

September 16, 2014

Presentation TCT 2014

Gender Differences in 1-Year Outcomes in Patients Treated with the Diamondback 360 Coronary Orbital Atherectomy System: Results from the ORBIT II Trial

Presenter: Christopher Kim

September 16, 2014

Presentation TCT 2014

Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients

Presenter: Ferdinando Varbella

September 16, 2014

Presentation TCT 2014

Patients At High Risk Of Bleeding, A Forgotten Population In DES Trials? Insights From The Ongoing LEADERS FREE Trial

Presenter: Philip Urban

September 16, 2014

Advertisement

Slides

ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold_

Two-Year Clinical Outcome of Patients With Implantation of Second-Generation Drug-Eluting Stents in the Right Coronary Ostium in the TWENTE Trial

Tissue Removal Assessment with Ultrasound of the SFA and Popliteal Study (TRUTH): Orbital Atherectomy Acute Data and Intravascular Ultrasound Analysis

Utility of Fractional Flow Reserve Assessment in Aortic Stenosis

Two-Year Clinical Results of Patients Randomized to 3- or 12-Month Dual Antiplatelet After Endeavor Zotarolimus Eluting Stent Implantation In OPTIMIZE

Predictors For Tissue Embolization During Transcatheter Aortic Valve Implantation

Short-Duration Versus Guideline-Recommended 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation

Gender Differences in 1-Year Outcomes in Patients Treated with the Diamondback 360 Coronary Orbital Atherectomy System: Results from the ORBIT II Trial

Carotid Artery Stenting with Double Cerebral Embolic Protection in Symptomatic Patients

Patients At High Risk Of Bleeding, A Forgotten Population In DES Trials? Insights From The Ongoing LEADERS FREE Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content